ArticleBMC medical informatics and decision making2026
Machine learning-based screening of sarcopenia in elderly women using non-invasive physiological signals.
Article in BMC medical informatics and decision making, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSarcopenia is the age related loss of skeletal muscle mass and strength, which increases frailty, fall risk, and healthcare costs. Conventional imaging based diagnostics are costly and impractical in routine clinical or community settings. We investigated whether noninvasive physiological signals, namely electrocardiography (ECG), electromyography (EMG), and center of pressure (COP), can serve as biomarkers for sarcopenia when analyzed with machine learning models.
methodsIn this study, 80 Korean women aged 65 to 75 years were assessed for sarcopenia using the 2019 Asian Working Group for Sarcopenia criteria (skeletal muscle mass index, hand grip strength, Short Physical Performance Battery). ECG, EMG, and COP signals were recorded under standardized laboratory conditions. Features that differed between participants with and without sarcopenia were identified using the Mann Whitney U test and then used to train support vector machine, neural network, random forest, and gradient boosting classifiers. Stratified ten fold cross validation evaluated accuracy, F1 score, precision, recall, and the area under the receiver operating characteristic curve (AUC).
resultsStatistically significant differences (p < 0.05) in physiological signal features were observed between sarcopenia and non-sarcopenia groups. ECG-based models consistently achieved the highest classification performance, with the SVM classifier reaching an accuracy of 93.2% and F1-score of 0.932. EMG- and COP-based models also demonstrated effective performance. Notably, for COP signals, models using only statistically significant features performed comparably or better than those utilizing the full feature set.
conclusionsNon-invasive physiological signals, particularly ECG-derived features, can effectively distinguish sarcopenia in elderly women in South Korea. Machine learning-based analysis offers a practical and scalable screening approach that complements existing diagnostic tools. This method has potential to enhance early detection efficiency and reduce diagnostic burden, especially in community and primary care settings.
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.